Stay updated on Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page.

Latest updates to the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous v3.6.4 tag. This indicates a page version update rather than a substantive change to the trial details.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a platform release. It does not modify study content or data on the page.SummaryDifference0.1%

- Check44 days agoChange DetectedA platform revision was applied, updating the site from version 3.6.2 to 3.6.3. This is a backend software update that does not change the study content.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a minor maintenance update to the study record page.SummaryDifference0.1%

- Check65 days agoChange DetectedThe recruitment status on the page was updated to show that enrollment is closed (No longer looking for participants), clarifying that the study is not accepting new participants.SummaryDifference0.4%

- Check73 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a new build of the page rather than a substantive change to the study details.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page.